Related Experiment Video
Updated: Jul 26, 2026

Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia (SCG)
Published on: January 30, 2009
Negative growth regulation of SK-N-MC cells by bFGF defines a growth factor-sensitive point in G2
V A Smits1, M A van Peer, M A Essers
1Jordan Laboratory, Department of Hematology, University Medical Center Utrecht G03.647, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
Abstract:
Basic fibroblast growth factor (bFGF) has been shown to induce growth inhibition of the neuroepithelioma cell line SK-N-MC. Here we show that this growth inhibition occurs in G(2). We show that bFGF is active on these cells during S and early G(2) phase. Therefore, this constitutes a rather unusual mechanism of growth inhibition, because it is generally believed that cells become refractory to extracellular signals after passage through the restriction point. We show that bFGF treatment inhibits Tyr-15 dephosphorylation of cdc2 and prevents activation of Cdc25C, similar to what is seen upon activation of the G(2) DNA damage checkpoint. Interestingly, both DNA damage- and bFGF-induced effects on cdc2 phosphorylation are reverted by caffeine. To confirm the involvement of similar pathways induced by bFGF and DNA damage, we generated tetracycline-regulatable SK-N-MC clones expressing Cdc25C-S216A. Expression of this Cdc25C mutant can revert the bFGF-induced effects on cdc2 phosphorylation and can rescue cells from the block in G(2) imposed by bFGF. Taken together, these data define a growth factor-sensitive point in G(2) that most likely involves regulation of Cdc25C phosphorylation.
Insights
Basic fibroblast growth factor (bFGF) inhibits neuroepithelioma cell growth in G2 phase, an unusual mechanism. This involves bFGF impacting cdc2 phosphorylation and Cdc25C activation, similar to DNA damage responses.
Area of Science:
- Cell cycle regulation
- Molecular biology
- Cancer research
Background:
- Basic fibroblast growth factor (bFGF) is known to inhibit the growth of the SK-N-MC neuroepithelioma cell line.
- Cellular responses to extracellular signals are typically thought to cease after the restriction point in the cell cycle.
Purpose of the Study:
- To investigate the mechanism by which bFGF induces growth inhibition in SK-N-MC cells.
- To identify the specific phase of the cell cycle affected by bFGF and the molecular players involved.
Main Methods:
- Cell cycle analysis of SK-N-MC cells treated with bFGF.
- Western blot analysis to assess cdc2 phosphorylation and Cdc25C activation.
- Generation and use of tetracycline-regulatable SK-N-MC clones expressing a Cdc25C mutant (Cdc25C-S216A).
Main Results:
- bFGF induces growth inhibition specifically during the G2 phase of the cell cycle.
- bFGF treatment inhibits Tyr-15 dephosphorylation of cdc2 and prevents Cdc25C activation, mimicking DNA damage responses.
- Caffeine treatment reverses both bFGF- and DNA damage-induced effects on cdc2 phosphorylation.
- Expression of Cdc25C-S216A rescues cells from bFGF-induced G2 block and normalizes cdc2 phosphorylation.
Conclusions:
- A novel growth factor-sensitive regulatory point exists in the G2 phase of the cell cycle.
- This G2 regulation likely involves the phosphorylation status of Cdc25C.
- bFGF utilizes pathways similar to DNA damage response pathways to control cell cycle progression.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Negative Regulator Molecules
Mitogens and the Cell Cycle
Cells Coordinate Growth and Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway

